Company:
Glasgow City Deal in partnership with Scottish Enterprise, North Lanarkshire Council, UK Business Innovation & Skills plus, the BioCity Group
Lead Advisor:
Andrew McGee
Sector:
Biotechnology, medtech, digital health and wellness
Role:
Business Acceleration and Development Manager on a new 3-year Glasgow City Deal initiative to identify early stage medtech, digital health and wellness start-ups with a business idea from across Scotland to apply for an be accepted onto a 12-week DEVELOP Acceleration Program.
Value Proposition:
MediCity Scotland’s DEVELOP Accelerator Program is a 12-week, highly practical opportunity for MedTech and Digital Health start-ups to develop a scalable business model. The program challenges business owners to seek out facts to validate their assumptions and pursue strategies that will accelerate their launch and development. MediCity Scotland is a ‘City Deal’ initiative in partnership with UK Business Innovation & Skills, Scottish Enterprise, North Lanarkshire Council and the BioCity Group
Results:
Contract Duration:
January 2016 to October 2017
Testimonials:
“Andrew has been instrumental in helping us transform our company from a disruptive clinical idea into a commercial business generating income. We've worked with Andrew for the past four years, through his posts at Alba Innovation then MediCity where we completed (and WON) the transformational DEVELOP programme. Andrew's unique combination of skills and experience has guided us through the many challenges we faced. His incredible network of contacts has enabled us to introduce missing skills into our team and he's facilitated introductions which have resulted in paying customers. It's rare to know someone with Andrew's passion which is matched in equal measure with his want to help businesses be the best they can be"
Kirsten Lord; Founder & CEO of PhysioMedics Limited
“I have had the pleasure of working with Andrew on a number of key projects which have focused on the translation and acceleration of innovative health and wellbeing opportunities. These have included detailed landscape mapping of key corporate players and alignment with start-up and scale-up ventures, capabilities and platforms with a focus on digital health. We have also conducted projects to assess venture viability for funding and potential partnerships. Andrew combines a highly personal approach in engaging with customers and partners and is able to quickly identify key points of differentiation and potential gaps, ranging from the business strategy and team to the technology platform. He has a great capability to connect global corporate players with start-ups whilst identifying routes to market and conducting due diligence for investors, applying strong customer discovery skills and facilitating the mindset of working with early-stage business ideas. I can personally highly recommend Andrew.”
David Browning; Managing Director MediCity UK (The BioCity Group)
Glasgow City Deal in partnership with Scottish Enterprise, North Lanarkshire Council, UK Business Innovation & Skills plus, the BioCity Group
Lead Advisor:
Andrew McGee
Sector:
Biotechnology, medtech, digital health and wellness
Role:
Business Acceleration and Development Manager on a new 3-year Glasgow City Deal initiative to identify early stage medtech, digital health and wellness start-ups with a business idea from across Scotland to apply for an be accepted onto a 12-week DEVELOP Acceleration Program.
Value Proposition:
MediCity Scotland’s DEVELOP Accelerator Program is a 12-week, highly practical opportunity for MedTech and Digital Health start-ups to develop a scalable business model. The program challenges business owners to seek out facts to validate their assumptions and pursue strategies that will accelerate their launch and development. MediCity Scotland is a ‘City Deal’ initiative in partnership with UK Business Innovation & Skills, Scottish Enterprise, North Lanarkshire Council and the BioCity Group
Results:
- 4 (12-week) DEVELOP accelerator programs delivered
- >28 new business ideas identified / supported
- Several one2one coaching sessions delivered
- £2.27m total investment secured by DEVELOP Accelerator Program cohorts - target set was over achieved; demonstrating the due diligence process & the success of the program
- 82% of Yr 1 specific targets (total of 11) for a new project were hit
- Client had never experienced such a rapid and positive result for a new project
- Organised and delivered a calendar of 20+ events and workshops
- Over 40 jobs helped to be created
- 3500 sq ft of office and lab space rented in the incubation centre
- Engaged with the Scottish Life Science Association as a Member
- Engaged with the Scottish Edge Awards Program as an Assessor
- Engaged with several of the Scottish Innovation Centres including the Data Lab, Censis, the Digital Health Institute, Stratified Medicine and the Imaging Centre of Excellence (ICE) at Glasgow University and Queen Elizabeth Hospital plus, several Scottish Universities.
Contract Duration:
January 2016 to October 2017
Testimonials:
“Andrew has been instrumental in helping us transform our company from a disruptive clinical idea into a commercial business generating income. We've worked with Andrew for the past four years, through his posts at Alba Innovation then MediCity where we completed (and WON) the transformational DEVELOP programme. Andrew's unique combination of skills and experience has guided us through the many challenges we faced. His incredible network of contacts has enabled us to introduce missing skills into our team and he's facilitated introductions which have resulted in paying customers. It's rare to know someone with Andrew's passion which is matched in equal measure with his want to help businesses be the best they can be"
Kirsten Lord; Founder & CEO of PhysioMedics Limited
“I have had the pleasure of working with Andrew on a number of key projects which have focused on the translation and acceleration of innovative health and wellbeing opportunities. These have included detailed landscape mapping of key corporate players and alignment with start-up and scale-up ventures, capabilities and platforms with a focus on digital health. We have also conducted projects to assess venture viability for funding and potential partnerships. Andrew combines a highly personal approach in engaging with customers and partners and is able to quickly identify key points of differentiation and potential gaps, ranging from the business strategy and team to the technology platform. He has a great capability to connect global corporate players with start-ups whilst identifying routes to market and conducting due diligence for investors, applying strong customer discovery skills and facilitating the mindset of working with early-stage business ideas. I can personally highly recommend Andrew.”
David Browning; Managing Director MediCity UK (The BioCity Group)
